Clinical Trial Detail

NCT ID NCT03706365
Title A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

prostate adenocarcinoma

Therapies

Abemaciclib + Abiraterone + Prednisone

Abiraterone + Prednisone

Age Groups: adult senior

No variant requirements are available.